Shareholders’ Deficit

6 Months Ended

Jun. 30, 2019

10.	Shareholders’ Deficit

Common Stock

We are authorized to issue 131,000,000 shares of common stock. Our common stock has a par value of $0.0001, no preferences or privileges and is not redeemable. Holders of our common stock are entitled to one vote for each share of common stock held.

We have reserved shares of common stock for the following as of June 30, 2019 (unaudited):

Shares to be issued upon conversion of all series of convertible preferred stock			93,039,737
Shares to be issued upon exercise of outstanding common stock options			17,681,436
Shares available for future stock option grants			3,155,968
Shares to be issued upon exercise of outstanding Series E-1 convertible preferred stock options			15,034
Shares to be issued upon conversion of Series C convertible preferred stock in connection with warrant exercise			56,875
Shares to be issued upon conversion of common stock warrants			55,032
Shares of common stock reserved for future issuance			114,004,082

Common Stock Warrants

In connection with two transactions in 2012 and 2013, we granted warrants to purchase up to 55,032 shares of common stock. The warrants are exercisable at any time for a period of ten years from the date of issuance at a weighted-average exercise price of $0.37, except in the case of a warrant to purchase 20,000 shares of common stock at an exercise price of $0.45 per share that would have expired if unexercised prior to the closing of our IPO.